Gabriele Ihorst

23PUBLICATIONS
70CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PhysiotherapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Oct 23, 2026
Extracorporeal photopheresis for the treatment of steroid-refractory immune related adverse events from immune checkpoint inhibitor therapy: a multi-center phase Ib/II clinical trial.

|Feb 27, 2026
Inpatient Rehabilitation Improves Physical and Mental Health in Multiple Myeloma: A Prospective Cohort Study.

Jan Räder, Andriani Vasakou, Gabriele Ihorst

|Dec 11, 2025
Role of Geriatric Assessment Scores as Predictors of Intensive Therapy Feasibility and Survival in Elderly Patients with Primary CNS Lymphoma.

Lisa K Isbell, Annika Vreden, Gabriele Ihorst

|Apr 14, 2025
Teduglutide for treatment-refractory severe intestinal acute graft-versus-host disease - a multicenter survey.

Niklas Brehm, Francesca Biavasco, Johannes Clausen

|Dec 17, 2024
Clinical Characteristics, Cytogenetic Risks, and Prognoses of Young Multiple Myeloma Patients in the Era of Novel Therapies.

Nathalie Borst, Gabriele Ihorst, Sina Wenger

|Sep 28, 2024
Evaluation of risk for bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation with myeloablative conditioning regimens.

Jesús Duque-Afonso, Paraschiva Rassner, Kristin Walther

Pageof 4

Frequent Collaborators

12 joint publications

Ralph Wäsch

8 joint publications

Robert Zeiser

6 joint publications

Jesús Duque-Afonso

5 joint publications

Jürgen Finke